HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Iengo Selected Research

dichlorotetrakis(dimethyl sulfoxide)ruthenium II (trans-Ru)

12/2000Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes.
9/2000Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Iengo Research Topics

Disease

4Neoplasms (Cancer)
12/2000 - 02/2000
3Carcinoma (Carcinomatosis)
02/2002 - 04/2000
3Neoplasm Metastasis (Metastasis)
02/2002 - 04/2000
1Lewis Lung Carcinoma
12/2000
1Adenocarcinoma
09/2000

Drug/Important Bio-Agent (IBA)

4imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA
02/2002 - 04/2000
4RutheniumIBA
12/2000 - 02/2000
2dichlorotetrakis(dimethyl sulfoxide)ruthenium II (trans-Ru)IBA
12/2000 - 09/2000
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
02/2002
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
02/2002
1Cysteine (L-Cysteine)FDA Link
02/2002
1Glutathione (Reduced Glutathione)IBA
02/2002
1LigandsIBA
02/2002
1SolutionsIBA
02/2002
1matrigelIBA
12/2000
1SodiumIBA
12/2000
1PlasticsIBA
09/2000
1Antineoplastic Agents (Antineoplastics)IBA
04/2000
1Biological ProductsIBA
02/2000